Bavarian Nordic AS (STU:BV3A) EPS (Basic): €0.68 (TTM As of Mar. 2026)


STU:BV3A Bavarian Nordic AS STU:BV3A
86 GF Score
Price €7.60
GF Value €7.14
! 2 Warning Signs
View Full Analysis

What is Bavarian Nordic AS EPS (Basic)?

Bavarian Nordic AS STU:BV3A +2.01% 86 EPS (Basic) is €0.68 as of Mar. 2026. GuruFocus rates STU:BV3A with a GF Score™ of 86/100 and a GF Value™ of €7.14. The stock has 2 warning signs investors should review.

Bavarian Nordic AS's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.68.

Bavarian Nordic AS's EPS (Diluted) for the three months ended in Mar. 2026 was €0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.68.

Bavarian Nordic AS's EPS without NRI for the three months ended in Mar. 2026 was €0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.68.

During the past 12 months, Bavarian Nordic AS's average EPS without NRIGrowth Rate was -8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Bavarian Nordic AS's highest 3-Year average EPS without NRI Growth Rate was 73.20% per year. The lowest was -66.80% per year. And the median was 9.80% per year.


Bavarian Nordic AS  (STU:BV3A) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Bavarian Nordic AS EPS (Basic) Related Terms


Bavarian Nordic AS EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Bavarian Nordic AS's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic AS EPS (Basic) Chart

Bavarian Nordic AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.33 -0.22 0.86 0.56 0.79

Bavarian Nordic AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.20 0.61 -0.15 0.01
STU:BV3A
86GF Score
Bavarian Nordic AS STU:BV3A
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bavarian Nordic AS EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Bavarian Nordic AS's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(184.149-0)/234.084
=0.79

Bavarian Nordic AS's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(2.268-0)/254.295
=0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €0.68 mean?
Bavarian Nordic AS (STU:BV3A) has a EPS (Basic) of €0.68 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Bavarian Nordic AS and its competitors.
Is Bavarian Nordic AS's EPS (Basic) too high?
Bavarian Nordic AS's current EPS (Basic) is €0.68. Overall, Bavarian Nordic AS has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's EPS (Basic) compare to VRTX and REGN?
Bavarian Nordic AS's EPS (Basic) of €0.68 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Bavarian Nordic AS and its competitors. Bavarian Nordic AS's current EPS (Basic) is €0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Bavarian Nordic AS (STU:BV3A) has a current EPS (Basic) of €0.68. The stock's GF Value™ is €7.14, compared to a current price of €7.60 — trading 6.4% above its estimated fair value. The current EPS (Basic) is €0.68. Bavarian Nordic AS's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Bavarian Nordic AS (STU:BV3A), the current EPS (Basic) is €0.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bavarian Nordic AS (STU:BV3A) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of €7.60 is trading 6.4% above its estimated GF Value™ of €7.14.

Key valuation signals for STU:BV3A:

  • EPS (Basic): €0.68
  • GF Value™: €7.14 vs. price of €7.60 (6.4% above fair value)
  • GF Score™: 86/100 with 2 warning signs

No single metric tells the full story. See the STU:BV3A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
86GF Score

Get the complete analysis for STU:BV3A

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.60
Price
€7.14
GF Value